Efficacy and safety of Aflibercept for the treatment of inflammatory choroidal neovascularization: The ALINEA study
Sign Up to like & getrecommendations! Published in 2022 at "Acta Ophthalmologica"
DOI: 10.1111/aos.15214
Abstract: To evaluate mean change in best‐corrected visual acuity (BCVA) at 52 weeks in patients with inflammatory choroidal neovascularization (CNV) treated with aflibercept. read more here.
Keywords: inflammatory choroidal; safety aflibercept; aflibercept treatment; choroidal neovascularization ... See more keywords
Efficacy and safety of aflibercept plus chemotherapy in metastatic colorectal cancer: A systematic review and PRISMA‐Compliant single‐arm Meta‐Analysis of noncomparative clinical studies and randomized controlled trials
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.13610
Abstract: Aflibercept, a recombinant protein designed to suppress the vascular endothelial growth factor (VEGF) signalling pathway, has been used in patients with metastatic colorectal cancer (mCRC). We conducted the first meta‐analysis to systematically review the efficacy… read more here.
Keywords: meta analysis; safety aflibercept; metastatic colorectal; colorectal cancer ... See more keywords
Efficacy and Safety of Aflibercept Therapy for Diabetic Macular Edema: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Current Ophthalmology"
DOI: 10.4103/joco.joco_308_21
Abstract: Purpose: To assess the real-world efficacy and safety of aflibercept for the treatment of diabetic macular edema (DME). Methods: A systematic search was conducted across multiple databases. Articles were included if participants had DME and… read more here.
Keywords: safety; safety aflibercept; wmd letters; therapy ... See more keywords